Doxiproct Plus, pommade rectale

7680389340152 CH-38934 pommade rectale

Associated product:

DOXIPROCT Plus ong tb 20 g
Doxiproct Plus, pommade rectale
Doxiproct Plus, pommade rectale
Doxiproct Plus, pommade rectale
1 / 3
google

Article details

Package size
20
Selling units
20
Measure
g
Galenic form
pommade rectale
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/06/2025
Patient information leaflet
Français
02/06/2025
Patient information leaflet
Italien
02/06/2025
Summary of Product Characteristics
Allemand
02/06/2025
Summary of Product Characteristics
Français
02/06/2025
Summary of Product Characteristics
Italien
02/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
0.25 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
60.0 MG Substance HBESI
(N/A)
309.0 MG Substance HBESI
(N/A)
- Substance ANTOX
(N/A)
150.0 UG Substance HBESI

Authorization holder

OM Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
38934
Drug name
Doxiproct Plus, pommade rectale
Galenic form
REKS
ATC Code
C05AA09
Authorization status
Z
Dispensing category
B
First authorization
22/04/1975
Authorization expiration date
31/12/9999
IT Number
02.09.2.
Domain
Human medicine

Package details

Description (FR)
DOXIPROCT Plus ong tb 20 g
Description (DE)
DOXIPROCT Plus Salbe Tb 20 g
Market launch
22/04/1975
Narcotic (BTM)
No